Sanofireported 3Q19 Synvisc revenue of €73 million (USD $82 million), +1.4% vs. 3Q18.
Sanofi’s U.S. viscosupplement sales rebounded somewhat after 2Q19, in which they were down double-digits year over year
Continued strength in emerging markets offset U.S. losses, bringing positive growth for Synvisc for the first time in 2019
ORTHOWORLD projects Sanofi full year 2019 Synvisc revenue of $356.1 million, +1.3% vs. 2018
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
3Q19
3Q18
$ Chg
% Chg
Orthobiologics
$82.0
$80.9
$1.1
1.4%
9Mo 19
9Mo 18
$ Chg
% Chg
Orthobiologics
$256.2
$260.7
($4.5)
(1.7%)
Geographic Sales
3Q19
3Q18
$ Chg
% Chg
US
$56.2
$57.3
($1.1)
(2%)
Ex-US
$25.8
$23.6
$2.2
9.5%
Europe
$5.6
$5.6
$0.0
0%
Emerging Markets
$15.7
$14.6
$1.1
7.7%
Rest of World
$4.5
$3.4
$1.1
33.3%
Total
$82.0
$80.9
$1.1
1.4%
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
Sanofireported 3Q19 Synvisc revenue of €73 million (USD $82 million), +1.4% vs. 3Q18.
Sanofi’s U.S. viscosupplement sales rebounded somewhat after 2Q19, in which they were down double-digits year over year Continued strength in emerging markets offset U.S. losses, bringing positive growth for Synvisc for the first time in 2019 ...
Sanofireported 3Q19 Synvisc revenue of €73 million (USD $82 million), +1.4% vs. 3Q18.
Sanofi’s U.S. viscosupplement sales rebounded somewhat after 2Q19, in which they were down double-digits year over year
Continued strength in emerging markets offset U.S. losses, bringing positive growth for Synvisc for the first time in 2019
ORTHOWORLD projects Sanofi full year 2019 Synvisc revenue of $356.1 million, +1.3% vs. 2018
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
3Q19
3Q18
$ Chg
% Chg
Orthobiologics
$82.0
$80.9
$1.1
1.4%
9Mo 19
9Mo 18
$ Chg
% Chg
Orthobiologics
$256.2
$260.7
($4.5)
(1.7%)
Geographic Sales
3Q19
3Q18
$ Chg
% Chg
US
$56.2
$57.3
($1.1)
(2%)
Ex-US
$25.8
$23.6
$2.2
9.5%
Europe
$5.6
$5.6
$0.0
0%
Emerging Markets
$15.7
$14.6
$1.1
7.7%
Rest of World
$4.5
$3.4
$1.1
33.3%
Total
$82.0
$80.9
$1.1
1.4%
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
